Dynamic Biotechnology & Genome Invesco ETF (PBE)

$71.83 0.85 (1.18%)

20:00 EDT PBE Stock Quote Delayed 30 Minutes

3 of the Best Biotech ETFs on the Market

By Todd Shriber, InvestorPlace Contributor Jan 2, 2020

The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.

7 Biotech ETFs That Should Remain Healthy

7 of the Best Biotech ETFs

7 Biotech ETFs to Consider for 2019

More Articles

Volume:

Previous Close -

Market Cap 2.74M

PE Ratio -

EPS -

Volume (Avg. Vol.) 6,018

Day's Range 71.76 - 72.86

52-Week Range 52.31 - 84.86

Dividend & Yield 0.00 (0.00%)

PBE Stock Predictions, Articles, and Dynamic Biotechnology & Genome Invesco ETF News

From InvestorPlace
From the Web

7 Benchmark-Clobbering ETFs to Buy

By Todd Shriber, InvestorPlace Contributor Sep 17, 2018

Finding the best ETFs to buy can be trying, particularly with the universe of smart beta funds rapidly expanding. These funds, however, beat even their benchmarks.

5 Biotech ETFs for Outsized Gains

By Todd Shriber, InvestorPlace Contributor Apr 25, 2018

Data support the notion that biotechnology stocks offer outperformance potential over diversified healthcare benchmarks. And these 5 biotech ETFs are a great to play the space.

Is Now the Time to Buy Into These 5 Biotech ETFs?

By Zacks Investment Research Mar 14, 2017

After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out

3 Biotech ETFs for Decades of Big Returns

By Aaron Levitt, InvestorPlace Contributor Nov 15, 2016

It doesn't matter who is in charge; biotech stocks will always be major growth engines. Here are three of the best biotech ETFs to buy.

4 Frightful ETFs of This Year (VXX, TAPR, KWT, BBC)

By Zacks Investment Research Oct 28, 2016

Let's take a look Inside four heavily losing ETFs in the year-to-date frame.

3 Unheralded Biotech ETFs to Buy Now

By Todd Shriber, InvestorPlace Contributor Jun 29, 2015

Want to join biotech stocks on the industry's seemingly never-ending run higher? Consider these lesser-known biotech ETFs.

3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover

From Benzinga Dec 14, 2020

The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a $39-...

ETFs in Focus on Bayer's Bet on Gene Therapy

From Talk Markets Oct 30, 2020

Merger and acquisition activities have heated up in recent months and the niche spaces are in the limelight. After the telemedicine industry, gene therapy stocks jumped on the bandwagon.

3 Health Care ETFs Where Components Are Enduring Downgrades

From Benzinga Sep 25, 2020

After setting scintillating paces earlier this thanks to the race to develop a coronavirus vaccine, some health care exchange-traded funds are languishing. What Happened: It could...